Status:
TERMINATED
A New Optical Sweat Test Method Based on a Citric Acid-derived Multi-halide Sensor
Lead Sponsor:
Milton S. Hershey Medical Center
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cystic Fibrosis (CF) is a hereditary multi-system disease affecting approximately 30,000n children and adults in the USA. The diagnosis of CF requires biochemical confirmation (either abnormal sweat c...
Eligibility Criteria
Inclusion
- Adults 18 years of age or older capable of providing written informed consent AND
- Patients with an established diagnosis of Cystic Fibrosis (CF) OR Healthy volunteers
Exclusion
- Participants under medications or with disorders known to cause a positive error in the sweat test will be excluded in the study. Common causes of positive error in sweat test are mineralocorticoid hormone therapy, adrenal insufficiency, glycogen storage diseases, hypothyroidism, hypoparathyroidism, nephrogenic diabetes insipidus, G6PD deficiency or ectodermal dysplasia OR
- Any other skin or soft tissue disorders that could affect obtaining the necessary volumes of sweat.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03367494
Start Date
March 1 2018
End Date
December 1 2020
Last Update
June 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States, 17033